9HVA | pdb_00009hva

Crystal structure of Fab34 complexed with a 18-mer peptide of FMDV VP1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.89 Å
  • R-Value Free: 
    0.279 (Depositor), 0.280 (DCC) 
  • R-Value Work: 
    0.233 (Depositor), 0.233 (DCC) 
  • R-Value Observed: 
    0.235 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9HVA

This is version 1.3 of the entry. See complete history

Literature

Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitope.

Bonnet-Di Placido, M.Duyvesteyn, H.M.E.Steyn, A.W.Hay, A.L.Porta, C.Valdez, K.R.Lokhman, E.Crossley, S.Hanson, K.Mwangi, W.N.Munir, D.Perez-Martin, E.Knowles, N.J.Burman, A.Yassin, A.A.Asfor, A.Faralla, C.Lam, K.J.McComb, R.Leifeld, C.Pietersz, K.King, D.P.van den Born, E.Duncan, S.K.Charleston, B.Fry, E.E.Ren, J.Stuart, D.I.Hammond, J.A.

(2026) NPJ Vaccines 11

  • DOI: https://doi.org/10.1038/s41541-026-01427-7
  • Primary Citation Related Structures: 
    9HV1, 9HV2, 9HV8, 9HV9, 9HVA

  • PubMed Abstract: 

    Foot-and-mouth disease virus (FMDV) causes a devastating disease that threatens global food security. Vaccination is hindered by antigenic diversity across serotypes. To identify cross-serotype neutralising epitopes, we isolated 24 FMDV-specific antibodies from cattle sequentially vaccinated with antigens from four serotypes, of which three neutralised three vaccine strains. These three antibodies neutralised 21 and bound 59 additional topotypes across O, A, Asia 1, and C serotypes. Cryo-EM complexes of Fabs with FMD virus-like particles indicated all three recognise a common flexible epitope at the VP1 C-terminus, confirmed by binding competition. Crystallography and structural modelling revealed that a normally inaccessible surface of the hydrophobic VP1 C-terminal peptides inserts into a similar groove in all three antibodies. Comparison of neutralisation activity and integrin receptor blocking by whole antibodies, F(ab') 2 s, and Fabs suggests neutralisation is mediated by Fc steric hindrance of receptor binding. This cryptic, linear, and cross-serotype neutralising epitope may inform improved FMD vaccines.


  • Organizational Affiliation
    • The Pirbright Institute, Pirbright, Surrey, UK.

Macromolecule Content 

  • Total Structure Weight: 299.29 kDa 
  • Atom Count: 19,818 
  • Modeled Residue Count: 2,663 
  • Deposited Residue Count: 2,814 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
heavy chain238Bos taurusMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
light chain213Bos taurusMutation(s): 0 
Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
Capsid protein VP118Foot-and-mouth disease virusMutation(s): 0 
UniProt
Find proteins for P03305 (Foot-and-mouth disease virus serotype O)
Explore P03305 
Go to UniProtKB:  P03305
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP03305
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.89 Å
  • R-Value Free:  0.279 (Depositor), 0.280 (DCC) 
  • R-Value Work:  0.233 (Depositor), 0.233 (DCC) 
  • R-Value Observed: 0.235 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 302.54α = 90
b = 111.906β = 115.99
c = 140.575γ = 90
Software Package:
Software NamePurpose
Cootmodel building
PHENIXrefinement
GDAdata collection
xia2data reduction
xia2data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Medical Research Council (MRC, United Kingdom)United KingdomMR/N00065X/ 1
Wellcome TrustUnited Kingdom060208/Z/00/Z

Revision History  (Full details and data files)

  • Version 1.0: 2026-01-14
    Type: Initial release
  • Version 1.1: 2026-04-08
    Changes: Database references
  • Version 1.2: 2026-04-15
    Changes: Database references
  • Version 1.3: 2026-06-03
    Changes: Database references